Targeting ER Acetylation to Rescue Proteotoxicity
International Journal of Biomedical Science · 2023
DOI: 10.59566/iabs.2023.p003 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biomedical Science, 2023. Verfasst von Luigi Puglielli.
Abstract (Originalsprache)
Transient acetylation within the endoplasmic reticulum (ER) lumen has emerged as a novel mechanism that regulates proteostasis and dynamics of the secretory pathway. The ER acetylation machinery includes AT-1, a membrane transporter that imports acetyl-CoA from the cytosol into the ER lumen, and two acetyltrasferases, ATase1 and ATase2, which acetylate ER cargo and resident proteins. Loss-of-function mutations or gene duplication events that affect ER acetylation are linked to developmental delay and premature death (homozygous mutation), hereditary forms of peripheral neuropathy (homozygous mutation), and autism spectrum disorder with intellectual disability and progeria (gene duplication). Mouse models of dysfunctional ER acetylation mimic associated human phenotypes.
Zitieren
APA
Puglielli, L. (2023). Targeting ER Acetylation to Rescue Proteotoxicity. International Journal of Biomedical Science. https://doi.org/10.59566/iabs.2023.p003
Vancouver
Puglielli L. Targeting ER Acetylation to Rescue Proteotoxicity. International Journal of Biomedical Science. 2023. doi:10.59566/iabs.2023.p003
BibTeX
@article{Puglielli2023,
author = {Puglielli, Luigi},
title = {Targeting ER Acetylation to Rescue Proteotoxicity},
journal = {International Journal of Biomedical Science},
year = {2023},
doi = {10.59566/iabs.2023.p003}
}
EUVIMED